Skip to content

XIENCE Sierra™ 1550400-33Recalls & reported problems

Abbott Vascular Inc. · XIENCE Sierra™ Everolimus Eluting Coronary Stent System 4.00 mm x 33 mm / Rapid-Exchange · Class 3 · Implant

All models of XIENCE Sierra (56)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 08717648227530), received between May 26, 2020 and Apr 8, 2024 — classified as 1 injury, 2 malfunctions.

The most frequently reported specific device problem is “Device Dislodged or Dislocated” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 1 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Device Dislodged or Dislocated1
  • Difficult to Remove1
  • Failure to Advance1
  • Improper or Incorrect Procedure or Method1
  • Off-Label Use1
  • Patient-Device Incompatibility1

Patient problems

  • No Consequences Or Impact To Patient2
  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • MalfunctionApr 8, 2024Improper or Incorrect Procedure or Method; Improper or Incorrect Procedure or Method

    SUBSEQUENTLY, AFTER THE INITIAL WAS FILED IT WAS NOTED THAT THE STENT WAS IMPLANTED IN THE MID RIGHT CORONARY ARTERY. NO ADDITIONAL INFORMATION WAS PROVIDED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 19061029 ↗
  • InjurySep 9, 2020Off-Label Use; Patient-Device Incompatibility; Off-Label Use; Patient-Device Incompatibility

    IT WAS REPORTED THAT THE PROCEDURE WAS PERFORMED TO TREAT A LESION IN THE TIBIAL ARTERY BELOW THE KNEE. AN UNSPECIFIED GUIDE WIRE WAS ADVANCED AND ATHERECTOMY WAS PERFORMED. AN UNSPECIFIED BALLOON CATHETER WAS ADVANCED AND THE LESION WAS DILATED; HOWEVER, A PERFORATION WAS NOTED. FIVE NON-ABBOTT STENTS WERE DEPLOYED AND TREATED THE PERFORATION IN THE ANTERIOR TIBIAL ARTERY. IN THE POSTERIOR TIBIAL ARTERY (PTA) FIVE XIENCE SIERRA STENTS (3.5X28MM, 3.5X38MM, 4.0X33MM, 4.0X38MM, AND 4.0X38MM) WERE DEPLOYED OVERLAPPING EACH OTHER. THREE OF THE STENTS SEALED THE AREA OF THE PERFORATION SUCCESSFULLY; HOWEVER, TWO OF THE STENTS (4.0X33MM AND 4.0X38MM) DID NOT. PROLONGED BALLOON INFLATION WAS DONE FOR 10 MINUTES AND THE PERFORATION WAS NOT SEALED AND THE PATIENT CONTINUED BLEEDING. A 4.0X19MM GRAFTMASTER COVERED STENT AND A 3.5X19MM GRAFTMASTER COVERED STENT WERE DEPLOYED ON TOP OF THE DEPLOYED 4.0X33MM AND 4.0X38MM XIENCE SIERRA STENTS TO SUCCESSFULLY TREAT THE LONG PERFORATION IN THE PTA. DUE TO THE LONG PERFORATION AND EXCESSIVE BLEEDING DURING TREATMENT THE PATIENT SUFFERED FROM COMPARTMENT SYNDROME AND WAS SENT TO SURGERY FOR A FASCIOTOMY ON THE SAME DAY. NO ADDITIONAL INFORMATION WAS

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 10512234 ↗
  • MalfunctionMay 26, 2020Difficult to Remove; Failure to Advance; Device Dislodged or Dislocated; Difficult to Remove; Failure to Advance; Device Dislodged or Dislocated

    IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A LESION LOCATED IN THE PROXIMAL LEFT ANTERIOR DESCENDING CORONARY ARTERY. AFTER A FAILED ATTEMPT TO CROSS WITH THE XIENCE STENT DELIVERY SYSTEM, THERE WAS RESISTANCE DURING REMOVAL AND THE STENT CAME OFF THE SHAFT. THE STENT WAS EASILY REMOVED WITH THE GUIDE WIRE WHEN THE GUIDE WIRE WAS REMOVED. THERE WAS NO REPORTED ADVERSE PATIENT EFFECT AND NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. A NON-ABBOTT STENT WAS USED TO COMPLETE THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 10089799 ↗

Other Coronary drug-eluting stent devices

All Coronary drug-eluting stent devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page